# A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects

> **NCT05171348** · PHASE1 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 40 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CM326
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05171348
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-07
- **Primary completion:** 2022-10-11
- **Final completion:** 2022-10-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171348, "A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05171348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*